Abstract
PURPOSE
The sudden onset of smell and taste loss has been reported as a symptom related to COVID-19. There is urgent need to provide insight to the pandemic and evaluate anosmia as a potential screening symptom that might contribute to the decision to test suspected cases or guide quarantine instructions.
METHODS
Systematic review of the PubMed/Medline, Cochrane databases and preprints up to May 3, 2020. Combined search terms included: "COVID-19", "SARS-CoV-2", "coronavirus", "nose", "anosmia", "hyposmia", "olfactory loss", "smell loss", "taste loss", and "hypogeusia".
RESULTS
Our search identified 18 reviewed articles and 6 manuscript preprints, including a large epidemiological study, four observational case series, five case-controlled studies, five cross-sectional studies, five case series of anosmic patients and four electronic surveys. Great methodological differences were noted. A significant prevalence of anosmia is reported in COVID-19 patients. Controlled studies indicate that anosmia is more common in COVID-19 patients than in patients suffering from other viral infections or controls. Most of the studies reported either smell loss or smell plus taste loss. Less severe COVID-19 disease is related to a greater prevalence of anosmia. A quick recovery of the smell loss may be expected in most COVID-19 cases.
CONCLUSION
Anosmia is more prevalent in COVID-19 patients than in patients suffering from other respiratory infections or controls.
TY - JOUR
T1 - The role of self-reported smell and taste disorders in suspected COVID‑19.
AU - Printza,Athanasia,
AU - Constantinidis,Jannis,
Y1 - 2020/05/23/
PY - 2020/05/09/received
PY - 2020/05/18/accepted
PY - 2020/5/25/pubmed
PY - 2020/8/18/medline
PY - 2020/5/25/entrez
KW - Anosmia
KW - COVID-19
KW - Loss of smell
KW - Olfactory dysfunction
KW - SARS-CoV-2
KW - Taste
SP - 2625
EP - 2630
JF - European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
JO - Eur Arch Otorhinolaryngol
VL - 277
IS - 9
N2 - PURPOSE: The sudden onset of smell and taste loss has been reported as a symptom related to COVID-19. There is urgent need to provide insight to the pandemic and evaluate anosmia as a potential screening symptom that might contribute to the decision to test suspected cases or guide quarantine instructions. METHODS: Systematic review of the PubMed/Medline, Cochrane databases and preprints up to May 3, 2020. Combined search terms included: "COVID-19", "SARS-CoV-2", "coronavirus", "nose", "anosmia", "hyposmia", "olfactory loss", "smell loss", "taste loss", and "hypogeusia". RESULTS: Our search identified 18 reviewed articles and 6 manuscript preprints, including a large epidemiological study, four observational case series, five case-controlled studies, five cross-sectional studies, five case series of anosmic patients and four electronic surveys. Great methodological differences were noted. A significant prevalence of anosmia is reported in COVID-19 patients. Controlled studies indicate that anosmia is more common in COVID-19 patients than in patients suffering from other viral infections or controls. Most of the studies reported either smell loss or smell plus taste loss. Less severe COVID-19 disease is related to a greater prevalence of anosmia. A quick recovery of the smell loss may be expected in most COVID-19 cases. CONCLUSION: Anosmia is more prevalent in COVID-19 patients than in patients suffering from other respiratory infections or controls.
SN - 1434-4726
UR - https://www.unboundmedicine.com/medline/citation/32447496/The_role_of_self_reported_smell_and_taste_disorders_in_suspected_COVID‑19_
L2 - https://dx.doi.org/10.1007/s00405-020-06069-6
DB - PRIME
DP - Unbound Medicine
ER -